Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:26 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 8,089,795 9.990% | 1,386,906 (+20.69%) | View |
| 2024-11-14 4:00 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL MANAGEMENT LLC | 7,811,760 9.990% | 7,811,760 (New Position) | View |
| 2024-11-14 3:03 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | Cormorant Asset Management LP | 0 0.000% | -5,750,000 (Position Closed) | View |
| 2024-11-14 12:28 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | JANUS HENDERSON GROUP PLC JHG | 4,809,518 6.200% | 651,408 (+15.67%) | View |
| 2024-05-22 4:06 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | JANUS HENDERSON GROUP PLC JHG | 4,158,110 5.300% | 4,158,110 (New Position) | View |
| 2024-05-13 4:00 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | Cormorant Asset Management LP | 5,750,000 7.380% | 5,750,000 (New Position) | View |
| 2024-02-14 4:00 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL PARTNERS LP | 6,550,000 9.800% | 3,039,555 (+86.59%) | View |
| 2024-02-14 10:09 am Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 6,702,889 9.990% | 107,088 (+1.62%) | View |
| 2024-02-13 5:02 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | VANGUARD GROUP INC | 4,902,943 7.320% | 317,222 (+6.92%) | View |
| 2023-02-14 4:13 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | Point72 Asset Management L.P. | 0 0.000% | -6,312,371 (Position Closed) | View |
| 2023-02-14 4:00 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL PARTNERS LP | 3,510,445 5.300% | 39,545 (+1.14%) | View |
| 2023-02-14 10:22 am Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | RTW INVESTMENTS LP | 0 0.000% | -6,029,700 (Position Closed) | View |
| 2023-02-09 11:16 am Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | VANGUARD GROUP INC | 4,585,721 6.940% | -522,270 (-10.22%) | View |
| 2022-07-29 4:37 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 6,595,801 10.100% | 792,101 (+13.65%) | View |
| 2022-07-25 4:00 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL PARTNERS LP | 3,470,900 5.300% | 3,470,900 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | BlackRock Inc. BLK | 1,826,591 2.800% | -3,135,771 (-63.19%) | View |
| 2022-02-14 4:43 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | Point72 Asset Management L.P. | 6,312,371 9.700% | 788,465 (+14.27%) | View |
| 2022-02-14 4:11 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,500,000 (Position Closed) | View |
| 2022-02-14 08:58 am Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | RTW INVESTMENTS LP | 6,029,700 9.200% | 161,374 (+2.75%) | View |
| 2022-02-09 3:43 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | VANGUARD GROUP INC | 5,107,991 7.830% | 2,173,567 (+74.07%) | View |